Education
About Us
Working with TipRanks
Follow Us
Ainos (AIMD)
NASDAQ:AIMD
AIMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.00 - $5.00
Previous CloseN/A
Volume220.33K
Average Volume (3M)4.82M
Market Cap
$17.05M
Enterprise Value$21.44M
Total Cash (Recent Filing)$1.22M
Total Debt (Recent Filing)$11.00M
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Nov 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding4,657,861
10 Day Avg. Volume98,070
30 Day Avg. Volume4,815,186
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue193.40
Enterprise Value/Gross Profit235.03
Enterprise Value/Ebitda-1.88
Forecast
1Y Price Target
$3.50Price Target Upside-3.58% Downside
Rating ConsensusHold
Number of Analyst Covering0
Ainos News
AIMD FAQ
What was Ainos’s price range in the past 12 months?
Ainos lowest stock price was $2.00 and its highest was $5.00 in the past 12 months.
What is Ainos’s market cap?
Ainos’s market cap is $17.05M.
When is Ainos’s upcoming earnings report date?
Ainos’s upcoming earnings report date is Nov 05, 2025 which is in 60 days.
How were Ainos’s earnings last quarter?
Ainos released its earnings results on Aug 13, 2025. The company reported -$0.991 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.991.
Is Ainos overvalued?
According to Wall Street analysts Ainos’s price is currently Overvalued.
Does Ainos pay dividends?
Ainos does not currently pay dividends.
What is Ainos’s EPS estimate?
Ainos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ainos have?
Ainos has 4,657,861 shares outstanding.
What happened to Ainos’s price movement after its last earnings report?
Ainos reported an EPS of -$0.991 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.69%.
Which hedge fund is a major shareholder of Ainos?
Currently, no hedge funds are holding shares in AIMD
Ainos Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.50 (-3.58% Downside)
$3.50 (-3.58% Downside)
Insider Transactions
Sold Shares
Worth $23.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▲ 22.2%
Last 30 Days ▲ 22.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.84%
12-Months-Change
Fundamentals
Return on Equity
-97.80%
Trailing 12-Months
Asset Growth
-32.69%
Trailing 12-Months
Company Description
Ainos
Ainos (AIMD) is a biotechnology company focused on developing innovative medical diagnostic solutions. The company specializes in point-of-care testing and is particularly known for its advanced breath analysis technology, which aids in the early detection and management of various medical conditions, including respiratory diseases and other metabolic disorders. Ainos operates within the healthcare sector, providing valuable diagnostic tools that enhance patient care and streamline clinical workflows.
Technical Analysis
Ibio
―
Kiora Pharmaceuticals
―
Aprea Therapeutics
―
Evaxion Biotech
―
Acurx Pharmaceuticals
―
Ownership Overview
27.01% Insiders
0.13% Mutual Funds
0.08% Other Institutional Investors
72.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---